Skip to content
Search

Latest Stories

Pakistan evaluating World Cup participation in India

Dates and venues of the once-in-four-year event are yet to be confirmed

Pakistan evaluating World Cup participation in India

PAKISTAN'S foreign ministry said it is "evaluating all aspects" of the country's participation in this year's 50-overs World Cup in India with bilateral cricket stalled between the south Asian neighbours due to soured political relations.

The two countries have played each other only in multi-team events at neutral venues over the last decade and doubts remain over Pakistan's involvement in the World Cup in October-November.

Pakistan's Bilawal Bhutto-Zardari was among the foreign ministers who travelled to India's Goa last month for a Shanghai Cooperation Organisation (SCO) meeting, becoming the first senior Pakistani leader to visit India in nine years.

Foreign ministry spokesperson Mumtaz Zahra Baloch said Pakistan was of the view that "politics should not be mixed with sports".

"India's policy of not playing cricket in Pakistan is disappointing," Baloch said in Islamabad on Thursday (22).

"We are observing and evaluating all aspects relating to our participation in the World Cup including the security situation for Pakistani cricketers and we will offer our views to PCB (Pakistan Cricket Board) in due course."

Doubts over Pakistan's participation have meant that the dates and venues for the World Cup are yet to be confirmed with just more than three months left before the start of the tournament.

India has already ruled out travelling to Pakistan for the Asia Cup, which is scheduled to begin on Augugst 31. In response, Pakistan threatened to boycott the World Cup if they lose the hosting rights to the Asia Cup.

Looking for a compromise, the Asian Cricket Council said the regional tournament will be hosted in a 'hybrid model' with four matches held in Pakistan and the remaining nine in Sri Lanka.

(Reuters)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less